BioNTech Eyes Construction Start for African Vaccine Factory in Mid-2022

Test tubes are seen in front of a displayed Biontech logo in this illustration taken, May 21, 2021. REUTERS/Dado Ruvic
Test tubes are seen in front of a displayed Biontech logo in this illustration taken, May 21, 2021. REUTERS/Dado Ruvic
TT

BioNTech Eyes Construction Start for African Vaccine Factory in Mid-2022

Test tubes are seen in front of a displayed Biontech logo in this illustration taken, May 21, 2021. REUTERS/Dado Ruvic
Test tubes are seen in front of a displayed Biontech logo in this illustration taken, May 21, 2021. REUTERS/Dado Ruvic

Germany's BioNTech, which developed a coronavirus jab with US pharmaceutical giant Pfizer, said Tuesday it aims to begin building a vaccine plant in Africa next year.

The project is expected to address the continent's shortage of COVID-19 vaccines and boost its flagging vaccination drive, with only 5.2 percent of its population fully inoculated, according to the Africa CDC.

BioNTech said it was working with authorities in both Rwanda and Senegal and plans to begin construction "in mid-2022".

The plant will initially have capacity to produce around 50 million vaccine doses per year, the German company said.

BioNTech had in August announced plans to build "sustainable vaccine production capabilities" in Rwanda and Senegal, producing not only COVID-19 vaccines but also mRNA-based malaria and tuberculosis vaccines.

“Together, we will work on developing a regional manufacturing network to support the access to vaccines manufactured in Africa, for Africa,” Chief Executive of BioNTech Ugur Sahin said.

In July, Pfizer and BioNTech announced that they were partnering with the Biovac Group to bottle their COVID-19 vaccine in Cape Town, South Africa, beginning in 2022.

However, the creation of the messenger RNA—the most delicate and crucial step—will continue to be carried out in Europe.

Currently, just one percent of vaccines used in Africa are manufactured on the continent. The African Union wants to increase this proportion to 60 percent by 2040.

US pharmaceutical giant Moderna earlier this month also announced plans to build a vaccine plant in Africa.

Africa, home to 1.2 billion people, is the least vaccinated continent in the world.

Test tubes are seen in front of a displayed Biontech logo in this illustration taken, May 21, 2021. REUTERS/Dado Ruvic



Russian Missile Kills Six, Injures 20 in Ukraine’s Zaporizhzhia

With the Zaporizhzhia nuclear power plant in the background, a bicyclist travels along a path in Nikopol, Ukraine, Sept. 2, 2024. Russian forces have controlled the plant since the first weeks of the war. (AP Photo/Evgeniy Maloletka)
With the Zaporizhzhia nuclear power plant in the background, a bicyclist travels along a path in Nikopol, Ukraine, Sept. 2, 2024. Russian forces have controlled the plant since the first weeks of the war. (AP Photo/Evgeniy Maloletka)
TT

Russian Missile Kills Six, Injures 20 in Ukraine’s Zaporizhzhia

With the Zaporizhzhia nuclear power plant in the background, a bicyclist travels along a path in Nikopol, Ukraine, Sept. 2, 2024. Russian forces have controlled the plant since the first weeks of the war. (AP Photo/Evgeniy Maloletka)
With the Zaporizhzhia nuclear power plant in the background, a bicyclist travels along a path in Nikopol, Ukraine, Sept. 2, 2024. Russian forces have controlled the plant since the first weeks of the war. (AP Photo/Evgeniy Maloletka)

A Russian missile attack on Ukraine's southeastern city of Zaporizhzhia on Tuesday killed six people, injured at least 20 more and destroyed a critical infrastructure facility, Ukrainian officials said.

Ivan Fedorov, the regional governor, said in a statement on the Telegram messaging app that a fire broke out as a result of the strike. Authorities did not say what the facility was.

Before the attack, Fedorov and Ukraine's Air Force announced a ballistic missile alert for the region.

Russia has recently stepped up attacks on Zaporizhzhia, using highly destructive guided bombs, which Ukrainian forces find hard to shoot down.

The city is an important logistical and industrial hub located about 40 km (25 miles) from the frontline. Moscow's troops partially occupy the Zaporizhzhia region, which is also home to Europe's largest nuclear power plant.

The Ukrainian president's chief of staff urged allies to give more support to counter Russian attacks.

"Violence must be stopped by strong actions," Andriy Yermak said on Telegram.